Head of Clinical Development
- Employer
- Intellia Therapeutics
- Location
- Cambridge, MA
- Posted date
- Oct 15, 2026
View more categories
- Discipline
- Clinical, Clinical Development, Clinical Research
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Genetown
By clicking apply, your email address will be shared with the employer.
Job Details
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How You Will Achieve More:
We are a pre-commercial gene-editing company developing potential once-and-done therapies for serious diseases. Our in vivo gene-editing therapy for hereditary angioedema (HAE) is pending FDA review and poised to become the first in vivo gene-editing therapy, if approved, to reach the U.S. market. Our two global Phase 3 trials in transthyretin (TTR) amyloidosis: one in cardiomyopathy and one in polyneuropathy are well underway.
Head of Clinical Development, reporting to the CMO, will be a member of the development leadership team, accountable for partnering closely with key stakeholders in defining development strategy and oversight of clinical development activities across Intellia portfolio, including HAE and TTR. The successful candidate will be responsible for leading the cross-functional Clinical Development Team, providing strategic and medical leadership for clinical development activities of product and pipeline candidates across disease areas, in alignment with corporate strategy. This position requires a highly motivated physician scientist with hands-on expertise and player coach collaborative leadership style in advancing product candidates to deliver life-changing medicines.
Responsibilities:
Build and lead a team of Medical Directors and Clinical Scientists, accountable for working collaboratively with key stakeholders in development to define development strategy and plan across company portfolio, including life-cycle management activities
Lead cross-functional Clinical Development Team meetings, providing strategic and medical leadership of clinical development activities across company products and pipelines, including HAE and TTR
Collaborate with other members of the development leadership team to contribute to building a collaborative culture and improving effectiveness of the development team
Drive scientifically robust evaluation of development strategy and plans, including robust literature review to assess development landscape, evaluation of development and regulatory pathways
Engage with external scientific and clinical trial experts, clinical and regulatory consultants, to develop scientifically robust study designs
Provide strategic guidance and leadership to the medical director and clinical science team, including hands-on authoring of clinical and regulatory documents, such as clinical sections of regulatory submissions, study protocols, investigator brochures, publications
Serve as lead author in clinical responses to regulatory authorities, related to review of protocols, INDs, BLA/MAA/JNDA, and other regulatory filings
Provide medical leadership and input in cross-functional team activities, including business development activities, non-clinical development, quality assurance, clinical operations, biostatistics, regulatory affairs and drug safety
Responsible for medical oversight of clinical trials, including medical monitoring of studies, adverse event reporting, and patient safety for all clinical trials across a development program.
Provide medical and scientific leadership in data analysis and interpretation, maintaining integrity, scientific rigor, and transparency
Serve as the spokesperson both internally and externally, as appropriate to communicate clinical results to a variety of audiences, including investigators and KOLs
Work within compliance to all applicable GCP/ ICH regulations
About You:
MD, MD/PhD, or equivalent, based in greater Boston area
Ability to be present regularly in the Cambridge MA office
Strong critical thinking skills, with ability to synthesize complex information, and exceptional communication skills, both verbal and written, with ability to author documents under tight timeline
10+ years of experience in clinical and/or medical function in the biopharmaceutical industry, with 7+ years of clinical development experience; neuromuscular or rare disease preferred but not required
Highly organized, outcome-oriented, self-motivated player coach with strong leadership and interpersonal skills and effective conflict management skills
Experience in innovative clinical study design, analysis of clinical data, publications, and working knowledge of biostatistics and pharmacokinetics/pharmacodynamics
Deep understanding of the drug development process from pre-IND through BLA
Experience interacting with health authorities in the US and EU
In-depth knowledge of ICH-GCP and other application regulatory guidelines
Ability to travel domestically and internationally (~15%)
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down.
The base salary for this position is expected to range between $394,254.00 - $481,866.00 USD per year.
The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors.
Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion.
For more information about Intellia’s benefits, please click here.
Company
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.
Change life stories with genome editing therapies!
Stock Symbol: NTLA
- Phone
- (857) 285-6200
- Location
- 400 Technology Square
Suite 100
Cambridge
Massachusetts
02139
